Author: jezzabellemente

PUTRAJAYA, Dec 20 (Bernama) — As the year draws to a close, Tourism Malaysia via the Shopping Malaysia Secretariat has organised the Miss SHOPhia Virtual Hunt 2021 in an effort to promote shopping activities in Malaysia through the country’s digital shopping icon, Miss SHOPhia.

Befitting the current situation as the world adopts the “new normal” for the tourism industry, the Miss SHOPhia Virtual Hunt campaign took place on 18 December 2021 through the Zoom platform, with a total of 111 participants from within and outside the country (ASEAN). Each group consisted of four participants, including members of the public, local media, and representatives from ASEAN countries including public and media.

Participants were virtually brought in to solve mystery riddles using the notion of street shopping, cuisine, and the most recent tourist attractions in Langkawi, Kuala Lumpur, Pulau Pinang, Kuching, and Kota Kinabalu. Participants stood a chance to win prizes worth up to RM39,000, subject to the terms and conditions.

Officiated by YBhg. Dato’ Haji Zainuddin Abdul Wahab, the Director General of Tourism Malaysia, the virtual hunt aimed to provide an escape for those who have been missing to visit and explore Malaysia. “The Covid-19 pandemic has forced us to rethink and postpone our holiday trips but as the saying goes “absence makes the heart grow fonder”, I believe it has made us yearn and ignite our dreams to travel even more,” said Dato’ Haji Zainuddin.

The event was concluded by Mr Iskandar Mirza Mohd Yusof, Deputy Director General (Planning) of Tourism Malaysia. “Through this event, the participants are able to get to know some of the new tourist attractions and food diversity in Malaysia through virtual lenses from the comfort of their homes. With the reopening of borders especially to Langkawi on 15th November 2021, we hope that by experiencing this virtual event all of you will be eager to plan your holiday to Malaysia,” said Mr Iskandar Mirza.

To get updates from Miss SHOPhia, visit https://www.instagram.com/miss_shophia/.

About Tourism Malaysia

Malaysia Tourism Promotion Board, also known as Tourism Malaysia, is an agency under the Ministry of Tourism, Arts & Culture Malaysia. It focuses on the specific task of promoting Malaysia as a preferred tourism destination. Since its inception, it has emerged as a major player in the international tourism scene. In 2019, Malaysia registered 26.1 million tourist arrivals and RM86.14 billion tourist receipts, placing it among the major tourism destinations of the world.

SOURCE: Tourism Malaysia

http://mrem.bernama.com/viewsm.php?idm=42005

Milan, Dec 21 (Bernama-GLOBE NEWSWIRE) —AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has won the 2021 Transatlantic Award from the American Chamber of Commerce in Italy (AmCham). The company was named the 2021 winner for its investments in the Italian biopharmaceutical industry, which includes expansion at its Center of Excellence in Milan to make it a global hub for cell and gene therapy innovation, development and manufacturing.

The annual award honors companies fostering economic development and growth between Italy and the United States. Luca Alberici, AGC Biologics General Manager and Site Head of the Milan facility, received the award on behalf of the company during the XV Transatlantic Award Gala Dinner, held on December 2 at Studio 90 East End Studios in Milan.

The additional guests of honor at the award ceremony included Mariangela Zappia (AmCham Italy Honorary President and Ambassador of Italy to the United States of America), Thomas D. Smitham (Chargé d’Affaires and interim and U.S. Embassy to Italy), On. Giancarlo Giorgetti (Italian Minister of Economic Development) and On. Lorenzo Guerini (Italian Minister of Defense).  AGC Biologics was honored alongside other notable companies such as Apple, Coca-Cola, Diasorin and KKR.

 “I am happy and honored to receive this award on behalf of AGC Biologics. This is an important award that showcases the investments our company has made in our Milan site, as well as the growing biopharmaceutical industry in our region,” said AGC Biologics Milan General Manager and Site Head, Luca Alberici. “Our Center of Excellence, one of the best in world and our team of scientists and employees, who work hard every day with responsibility and professionalism, played a crucial role in the successes we’ve achieved over the last two years.”

AGC Biologics acquired the Milan facility when it purchased Molecular Medicine S.p.A. (“MolMed”) in 2020. Since that transaction, AGC Biologics has focused on supporting and developing the teams working at the site, and investing in expanding the site’s services, capabilities and production capacities. These commitments in the Milan facility have helped AGC Biologics become one of the most complete and active biotech CDMOs in the global healthcare market.

The AGC Biologics Milan site was the first GMP facility approved in Europe for ex-vivo gene therapy manufacturing and has industry-unique commercial manufacturing experience, having previously brought three cell & gene therapy products to the market.

To complement the Center of Excellence in Milan, the company recently opened a new facility in Longmont, CO., USA, which will help AGC Biologics expand its global capacity for cell and gene therapy development and manufacturing. Through these two key sites, AGC Biologics can now offer more capacity and services to pharmaceutical companies worldwide developing new life-changing cell and gene therapy products.

About AGC Biologics
AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan and we currently employ more than 2,000 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is the partner of choice. To learn more, visit www.agcbio.com.

Nick McDonald
AGC Biologics
(425) 419-3555
nmcdonald@agc.com 

SOURCE : AGC Biologics

— VNYE to Return with Immersive New Year’s Eve Experience —

NEW YORK, Dec 17 (Bernama-BUSINESS WIRE) — The world’s biggest New Year’s Eve party is returning to the metaverse this year with the relaunch of VNYE, an immersive virtual experience set in the epicenter of New Year’s Eve: Times Square. Through the VNYE app and website, people from across the globe can explore the virtual world of Times Square, play games, and livestream New Year’s Eve celebrations in Times Square and around the world.

This press release features multimedia. View the full release here: 
https://www.businesswire.com/news/home/20211216006118/en/

Jamestown, the owner of One Times Square, which is the site of the New Year’s Eve Ball Drop Celebration, launched VNYE last year as a new way to celebrate New Year’s Eve amid the pandemic and cancellation of in-person celebrations. In total, VNYE reached more than 3.7 million people worldwide in 2021.

“We created VNYE to amplify the New Year’s Eve experience and keep the world connected to Times Square when physical access was limited,” said Michael Phillips, President of Jamestown. “In its second iteration, VNYE will both complement the return of in-person celebrations and serve as a destination in its own right—an immersive virtual world where people from across the globe can gather to celebrate the New Year.”

“Times Square New Year’s Eve is a global celebration that connects the world as we collectively say goodbye to the year past and look with hope to the year ahead,” said Tom Harris, President of the Times Square Alliance. “Jamestown has deepened those connections through this innovative VNYE technology allowing people from around the globe to interact with Times Square and this iconic celebration in ways that we never imagined.”

In the VNYE metaverse, users can create personalized avatars, explore the Times Square Plazas, collect confetti to earn points for additional avatar customizations, and visit the observation deck at One Times Square to view the virtual world of Times Square from above.

Inside One Times Square, users can discover three unique and immersive games: Dance World, where users show off their dance skills; Nature World, where users can take in various nature landscapes and engage in a scavenger hunt to collect pieces of the iconic New Year’s Eve Ball; and Zero G, where users can travel around the globe through a slide experience, visiting an array of the world’s landmarks while earning power-ups and points along the way.

Starting December 31, 2021, users can choose from 11 live camera feeds in Times Square and seven EarthCam live streams of New Year’s Eve celebrations from around the globe, including in Rio de Janeiro, Brazil, and Budapest, Hungary.

At midnight on New Year’s Eve, users can ring in the new year in the Times Square metaverse with a virtual Ball Drop Celebration and fireworks show.

The VNYE app will be available to download in app stores starting December 18, 2021, with livestreams starting December 31, 2021. For more information, visit VNYE.com and follow along at @onetimessquarenyc.

About Jamestown

Jamestown is a global, design-focused real estate investment and management firm with a 38-year track record and mission to create places that inspire. Since its founding in 1983, Jamestown has executed transactions in excess of $35 billion. As of September 30, 2021, Jamestown has assets under management of $13.1 billion and a portfolio spanning key markets throughout the U.S., Latin America, and Europe. Jamestown employs more than 400 people worldwide with headquarters in Atlanta and Cologne, and offices in Amsterdam, Bogotá, Boston, London, Los Angeles, Madrid, Milan, New York, San Francisco, and Washington, D.C. Current and previous projects include One Times Square and Chelsea Market in New York, Industry City in Brooklyn, Ponce City Market in Atlanta, Ghirardelli Square in San Francisco, the Innovation and Design Building in Boston, and Groot Handelsgebouw in Rotterdam. For more information, visit www.jamestownlp.com.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20211216006118/en/

Contact

Lisa Serbaniewicz
Jamestown
Lisa.Serbaniewicz@JamestownLP.com

One Times Square:
Elizabeth Latino / Siobhan Stocks-Lyons
Marino
Elatino@marinopr.com / SStocks-Lyons@marinopr.com

Source : Jamestown

–BERNAMA

TAIZHOU, China, Dec 17 (Bernama-BUSINESS WIRE) — The “2021 Hehe Culture Global Forum” was held both online and offline in Tiantai County, Taizhou City, Zhejiang Province on December 9. This forum was hosted by the China International Communication Group (CICG), the Information Office of the People’s Government of Zhejiang Province, and the People’s Government of Taizhou City, and organized by the Academy of Contemporary China and World Studies, the Information Office of the People’s Government of Taizhou City, the People’s Government of Tiantai County, and so on.

This press release features multimedia. View the full release here: 
https://www.businesswire.com/news/home/20211216005644/en/

Du Zhanyuan, President of China International Communication Group (CICG); Wu Jing, Vice Chairman of the Zhejiang Provincial Committee of the Chinese People’s Political Consultative Conference; Yukio Hatoyama, former Prime Minister of Japan and Chairman of the East Asian Community Institute; Han Nathan, Consul General of the Republic of Malta in Shanghai; and Li Yueqi, Secretary of the Taizhou Municipal Committee of the CPC, delivered opening speeches. Lu Cairong, Vice President of CICG, presided over the opening ceremony. About 150 people participated in discussions, including government dignitaries from a dozen countries such as China, Japan, South Korea and France, representatives of international organizations, foreign envoys in China, international sinologists, and experts and scholars from relevant think tanks, universities, and research institutions.

Du Zhanyuan pointed out that the Hehe culture, which originated in Tiantai Mountain, can provide positive inspiration for improving global governance and tackling challenges facing mankind. We should foster win-win cooperation and build an open global economy.

Yukio Hatoyama stated that two sides with different views on diplomacy should not refute each other’s viewpoints. Instead, we must work hard to achieve reconciliation in order to have win-win outcomes.

In the sub-forums, Chinese and foreign guests held exchanges and discussions on topics such as “maintaining harmony and common prosperity and achieving inclusive development”, and “working together for win-win cooperation”.

During the forum, CICG, the Publicity Department of Zhejiang Provincial Party Committee, and the Taizhou Municipal Party Committee and Municipal Government signed the Framework Agreement for Organizing Hehe Culture Global Forum on an Institutional Basis (2022-2024). The promotion and release of the multilingual Keywords to Understand China and the “Tiantai Mountain Hehe Culture” event were held during the forum.

Hehe Culture Global Forum is an institutionalized international conference. Starting in 2022, the forum will host international conferences and supporting events every year.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20211216005644/en/

Contact

Zhou Biye
Phone: 0086576-88510329
E-mail: tzswwxb001@163.com

Source : Hehe Culture Global Forum

–BERNAMA

SNOMED International released today its refreshed SNOMED CT Case for Investment report.

London, United Kingdom, Dec 17 (Bernama-GLOBE NEWSWIRE) — SNOMED International released today its refreshed SNOMED CT Case for Investment report. Available on a new interactive platform, the Case for Investment presents evidence that SNOMED CT adds measurable value to a broad range of primary and secondary health processes leveraging SNOMED CT encoded data to enable improved patient outcomes. Through the narrative, the report provides accessible and understandable answers to questions such as, “what is SNOMED CT?”, ‘what makes SNOMED CT unique?’, “how and where is it in use globally?” and “why invest in SNOMED CT?”

SNOMED CT, the most comprehensive and multilingual clinical healthcare terminology in the world, possesses unique characteristics that differentiate it from other classifications and terminologies. Among these characteristics are SNOMED CT’s position as a core reference terminology, its clinically comprehensive 350,000+ concepts supported by a machine-readable semantic network, broad use and mandate in select countries.

Showcasing real world use and outcomes of SNOMED CT is the best way to demonstrate its value, understanding that SNOMED CT must be embedded in a clinical information system, health data & analytics platform or an interoperability solution for it to function. Through the Case for Investment, 10 examples of SNOMED CT use across data entry and integration, clinical information sharing, point of care analytics, population and management analytics and research domains have been featured. Ranging across different countries such as Australia, Canada, China, United Kingdom, United States, continued collection of additional SNOMED CT case studies remains an ongoing priority.

SNOMED International CEO, Don Sweete, commented on the development and outcomes of the Case for Investment. “There has been a tremendous evolution in SNOMED CT over the past 10 years and this report demonstrates the value that it offers healthcare systems and stakeholders worldwide” said Sweete. “With a complement of 41 Members that represent health systems globally, continuously refreshed knowledge and analysis on the nature, utility and value of standards like SNOMED CT can’t be overstated. Health system decision-makers need to be equipped with clear knowledge of how their investments in SNOMED CT translate into positive outcomes for the health of their nation’s citizens.”

In terms of conclusions, the report presents SNOMED CT as a scalable and “fit for purpose” clinical terminology, adhering to international criteria, data quality and suitability requirements. A part of the bigger picture, SNOMED CT is one of many contributing factors to improving patient outcomes, and studies show that the use of SNOMED CT-embedded systems can provide significant qualitative and quantitative patient outcome benefits.

Looking forward, SNOMED CT must also contemplate how it enables the future needs of medicine and research. A healthcare industry that is ever evolving, the future opportunities for SNOMED CT will be driven by new healthcare data sources and new healthcare technologies such as national cohorts, big data and AI, clinical genomics, phenomics and environment, etc.

Experience the breadth of the SNOMED CT Case for Investment through the organization’s interactive value platform at value.snomed.org.

Attachment

• Explore the value of SNOMED CT

Kelly Kuru
SNOMED International
comms@snomed.org

SOURCE : SNOMED International